CHOP announced that PCORI approved a five year award to fund PRESERVE 2.0 – the largest randomized trial on blood pressure management in children with CKD. Children’s Hospital of Philadelphia (CHOP) announced that the Patient-Centered Outcomes Research Institute (PCORI) approved a five‑year funding award to support PRESERVE 2.0, a research project entitled “Alternative Approaches for Managing Blood Pressure in Children With Chronic Kidney Disease.” The study is set to become the largest randomized controlled trial focused on blood pressure management in children with chronic kidney disease (CKD).Hypertension affects roughly half of children with CKD and is a major, modifiable driver of kidney function decline. Loss of kidney function can lead to kidney failure requiring dialysis or transplant. Despite this, high-quality evidence guiding exactly how tightly to control blood pressure and which drugs to use as first-line therapy in most pediatric CKD patients is limited, resulting in wide practice variation and suboptimal blood pressure control for many children. PRESERVE 2.0 aims to fill these evidence gaps.The five-year study, which evolved from the original PCORnet® designated PRESERVE study, will launch in October 2026 and will be led by Co-Principal Investigators, Michelle Denburg, MD, MSCE and Christopher Forrest, MD, PhD at CHOP. The study will enroll 700 children ages 2 to 17 with CKD stages 2 to 4 across 30 U.S. healthcare institutions within PEDSnet and the other six PCORnet® clinical research networks. Participants will be followed for 24 months to compare two blood pressure goals – the usual target and a lower, more intensive target, and to see which first-line blood pressure medicines work better and are safer. Ultimately, PRESERVE 2.0 will answer two high-priority questions for pediatric CKD care: which clinic blood pressure target best protects kidney and heart health, and which medication class should be used first-line to treat hypertension in children with CKD. Michelle Denburg, MD, MSCE “If successful, PRESERVE 2.0 will provide the strongest available evidence about BP targets and first-line antihypertensive choice for most children with CKD,” said Denburg, who is also an attending physician in CHOP’s Division of Nephrology, and co-director of the Penn-CHOP Kidney Innovation Center. “Results are expected to directly inform clinical practice, guideline development, and shared decision-making tools for children with CKD, their families, and clinicians. Findings will be widely disseminated via webinars, infographics, videos, and professional meetings.”Learn more

PARASOL Project expands to focus on APOL1 kidney disease and primary membranous nephropathy, aiming to improve clinical trial endpoints for these conditions.

Visual scoring of tubular damage has limitations in capturing the full spectrum of structural changes and prognostic potential. Here, we investigated if computationally quantified tubular features can...

In test of NIH director’s support of dissent, NIH staff sign Bethesda Declaration urging reversal of grant cuts and freezes

Estimation of glomerular filtration rate (GFR) assumes that creatinine generation (crG) is relatively stable. This study identified factors associated…

Curtailment of freedoms and disregard for the rule of law in the United States is destroying the ability of science to serve the nation’s, and the world’s, interests. Researchers can take action. Curtailment of freedoms and disregard for the rule of law in the United States is destroying the ability of science to serve the nation’s, and the world’s, interests. Researchers can take action.

The Maine Republican could use her chair at Senate Appropriations to push back.

ALT: the word alert is in a purple circle

Amid negotiations with Trump, the university could risk losing nearly $700 million

The University of Washington plans to provide the affected students access to legal services that are paid for by their student fees.

The University announced its consideration to sell approximately $320 million of taxable bonds on Tuesday, following a notification from government agencies about the suspension of research grants.

The Georgetown Graduate School of Arts and Sciences is offering resources to assist in federal workforce transitions. Check out our career seminars to learn more.

Serving the Brown community since 1891

ALT: a cartoon of homer simpson holding a card

Administration officials pressured NIH to avoid clear advice from the agency’s own lawyers to restart grant funding now.

ALT: a muppet news anchor says " and now a muppet news flash " while holding a piece of paper

A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of heightened sensitivity about how the

The US Food and Drug Administration (FDA) has granted approval to the MediBeacon TGFR System for evaluating kidney function.

Researchers facing

In part 2 of 4 from this episode, the discussion focuses on the groundbreaking work of the RADAR Registry and the PARASOL Initiative.

The exclusion of Blacks/African-Americans, Latinx/Hispanics, and Indigenous people from science has resulted in their underrepresentation in the biomedical workforce, especially in academia. Faculty d...